The Czech Clinical Research Institute (CCRI) will support patients and physicians in the Czech Republic and Slovakia in accessing innovative treatments by expanding Clinerion’s hospital and patient coverage into those countries.
Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical studies and the use of Patient Network Explorer for academic research. Georgian Medical Software – MEDSOFT, an EHR supplier, will support Clinerion in expanding its footprint in Georgia.
CStone Pharmaceuticals announced that the National Medical Products Administration (NMPA) recently approved the clinical trial application (CTA) to start a Phase I clinical trial in China for BLU-554 (CS3008).
Biokin Pharmaceutical Co. Ltd. a leading pharmaceutical company with operations in China and U.S., and Cryoport, Inc. , the world's leading temperature-controlled logistics company dedicated to the life sciences industry.
Bavarian Nordic A/S announced , that the first stage of a Phase 2 study of its novel, targeted cancer immunotherapy candidate, BN-Brachyury in the treatment of advanced chordoma has completed recruitment of the planned 10 patients ahead of schedule.